Entrapment enhancement of peptide drugs in niosomes

The objective of this study was to enhance the entrapment of various charged peptide drugs [(bacitracin (BCT), insulin and bovine serum albumin (BSA)] in niosomes by modifying the vesicular charge compositions. Cationic, anionic and neutral niosomes were prepared from sorbitan monostearate (Span 60)...

Full description

Saved in:
Bibliographic Details
Main Authors: Manosroi A., Khanrin P., Werner R.G., Gtz F., Manosroi W., Manosroi J.
Format: Article
Language:English
Published: 2014
Online Access:http://www.scopus.com/inward/record.url?eid=2-s2.0-77951455054&partnerID=40&md5=7af3176cee6a76e5045b559e4f82205f
http://www.ncbi.nlm.nih.gov/pubmed/20113169
http://cmuir.cmu.ac.th/handle/6653943832/4504
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English
id th-cmuir.6653943832-4504
record_format dspace
spelling th-cmuir.6653943832-45042014-08-30T02:42:31Z Entrapment enhancement of peptide drugs in niosomes Manosroi A. Khanrin P. Werner R.G. Gtz F. Manosroi W. Manosroi J. The objective of this study was to enhance the entrapment of various charged peptide drugs [(bacitracin (BCT), insulin and bovine serum albumin (BSA)] in niosomes by modifying the vesicular charge compositions. Cationic, anionic and neutral niosomes were prepared from sorbitan monostearate (Span 60) or polyoxyethylene sorbitan monostearate (Tween 61), cholesterol (CHL), dimethyldioctadecylammonium bromide (DDAB) and/or dicetyl phosphate (DP) in distilled water, by freeze dried empty liposome (FDEL) method. Morphology and vesicular sizes of the vesicles were investigated by optical microscope, TEM, X-ray diffractometry and dynamic light scattering. The entrapment efficiency of the peptides in niosomes was determined by gel electrophoresis and gel documentation. After reconstitution of the empty niosomal powder in phosphate buffer pH 7.0 containing the peptide drugs, they were oligolamellar membrane structure, with the sizes of 40-60 nm, except the neutral niosomes entrapped with insulin and cationic niosomes entrapped with BSA which showed the sizes of 0.1-1.3 μm and 100-150 nm, respectively. The zeta potential values of neutral, cationic and anionic niosomes entrapped with BSA, insulin and BCT were -22.3±1.52, -30.7±2.92 and ±22.68±1.31 mV, respectively. The entrapment efficiency of BSA, BCT and insulin in neutral niosomes (Tween 61/CHL at 1 : 1 molar ratio) was 72.94, 69.89 and 10.26%, in cationic niosomes (Tween 61/CHL/DDAB at 1 : 1 : 0.05 molar ratio) was 84.54, 32.85 and 87.15% and in anionic niosomes (Tween 61/CHL/DP at 1 : 1 : 0.05 molar ratio) was 50.13, 90.88 and 44.31%, respectively. The highest entrapment efficiency of BSA, BCT and insulin at 72.94, 90.88 and 87.15 was observed in neutral, anionic and cationic niosomes, respectively. The results from this study has suggested the appropriate niosomal formulation to entrap the peptides with different charges and polarity for pharmaceutical application. © 2010 Informa UK Ltd. 2014-08-30T02:42:31Z 2014-08-30T02:42:31Z 2010 Article 2652048 10.3109/02652040903131293 20113169 JOMIE http://www.scopus.com/inward/record.url?eid=2-s2.0-77951455054&partnerID=40&md5=7af3176cee6a76e5045b559e4f82205f http://www.ncbi.nlm.nih.gov/pubmed/20113169 http://cmuir.cmu.ac.th/handle/6653943832/4504 English
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
language English
description The objective of this study was to enhance the entrapment of various charged peptide drugs [(bacitracin (BCT), insulin and bovine serum albumin (BSA)] in niosomes by modifying the vesicular charge compositions. Cationic, anionic and neutral niosomes were prepared from sorbitan monostearate (Span 60) or polyoxyethylene sorbitan monostearate (Tween 61), cholesterol (CHL), dimethyldioctadecylammonium bromide (DDAB) and/or dicetyl phosphate (DP) in distilled water, by freeze dried empty liposome (FDEL) method. Morphology and vesicular sizes of the vesicles were investigated by optical microscope, TEM, X-ray diffractometry and dynamic light scattering. The entrapment efficiency of the peptides in niosomes was determined by gel electrophoresis and gel documentation. After reconstitution of the empty niosomal powder in phosphate buffer pH 7.0 containing the peptide drugs, they were oligolamellar membrane structure, with the sizes of 40-60 nm, except the neutral niosomes entrapped with insulin and cationic niosomes entrapped with BSA which showed the sizes of 0.1-1.3 μm and 100-150 nm, respectively. The zeta potential values of neutral, cationic and anionic niosomes entrapped with BSA, insulin and BCT were -22.3±1.52, -30.7±2.92 and ±22.68±1.31 mV, respectively. The entrapment efficiency of BSA, BCT and insulin in neutral niosomes (Tween 61/CHL at 1 : 1 molar ratio) was 72.94, 69.89 and 10.26%, in cationic niosomes (Tween 61/CHL/DDAB at 1 : 1 : 0.05 molar ratio) was 84.54, 32.85 and 87.15% and in anionic niosomes (Tween 61/CHL/DP at 1 : 1 : 0.05 molar ratio) was 50.13, 90.88 and 44.31%, respectively. The highest entrapment efficiency of BSA, BCT and insulin at 72.94, 90.88 and 87.15 was observed in neutral, anionic and cationic niosomes, respectively. The results from this study has suggested the appropriate niosomal formulation to entrap the peptides with different charges and polarity for pharmaceutical application. © 2010 Informa UK Ltd.
format Article
author Manosroi A.
Khanrin P.
Werner R.G.
Gtz F.
Manosroi W.
Manosroi J.
spellingShingle Manosroi A.
Khanrin P.
Werner R.G.
Gtz F.
Manosroi W.
Manosroi J.
Entrapment enhancement of peptide drugs in niosomes
author_facet Manosroi A.
Khanrin P.
Werner R.G.
Gtz F.
Manosroi W.
Manosroi J.
author_sort Manosroi A.
title Entrapment enhancement of peptide drugs in niosomes
title_short Entrapment enhancement of peptide drugs in niosomes
title_full Entrapment enhancement of peptide drugs in niosomes
title_fullStr Entrapment enhancement of peptide drugs in niosomes
title_full_unstemmed Entrapment enhancement of peptide drugs in niosomes
title_sort entrapment enhancement of peptide drugs in niosomes
publishDate 2014
url http://www.scopus.com/inward/record.url?eid=2-s2.0-77951455054&partnerID=40&md5=7af3176cee6a76e5045b559e4f82205f
http://www.ncbi.nlm.nih.gov/pubmed/20113169
http://cmuir.cmu.ac.th/handle/6653943832/4504
_version_ 1681420249678741504